Hyderabad Telangana, India

Anitha Naredla

USPTO Granted Patents = 1 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anitha Naredla: Innovator in Pharmaceutical Chemistry

Introduction

Anitha Naredla is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel crystalline forms of medications. His work is characterized by a commitment to enhancing the efficacy and stability of pharmaceutical compounds.

Latest Patents

Anitha Naredla holds 1 patent for his innovative work on "Crystalline forms of vilazodone hydrochloride and vilazodone free base." This patent relates to the development of crystalline and amorphous forms of Vilazodone hydrochloride. Additionally, it covers amorphous solid dispersions of vilazodone hydrochloride with pharmaceutically acceptable carriers. The application also details a process for the preparation of form I of vilazodone free base, showcasing his expertise in pharmaceutical formulations.

Career Highlights

Anitha Naredla is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its commitment to innovation and quality in drug development. His role at the company allows him to apply his knowledge and skills in a practical setting, contributing to the advancement of healthcare solutions.

Collaborations

Throughout his career, Anitha has collaborated with notable colleagues, including Javed Iqbal and Srinivas Oruganti. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Anitha Naredla's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His work on vilazodone hydrochloride not only enhances the understanding of pharmaceutical formulations but also paves the way for improved therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…